Metraipolis › archive › dc_a14a01f38bef

Integrative multi-omics and experimental analyses implicate PTK2 as a lorazepam-associated biomarker and potential therapeutic target in ovarian cancer — Europe PMC PMID:41657774

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41657774
DOI
10.3389/fphar.2025.1744802
License (as archived)
solo-consultazione
Archived
2026-11-06T13:04:29.802Z
SHA-256 of the archived text
1a1ad681ed0867f4b3db1607b591718e1fa23af2d3ac30c52682f0f09f92ef85
Stable URL of this page
https://metraipolis.com/documento/dc_a14a01f38bef

How to cite

Integrative multi-omics and experimental analyses implicate PTK2 as a lorazepam-associated biomarker and potential therapeutic target in ovarian cancer — Europe PMC PMID:41657774 — Europe PMC (en), https://europepmc.org/article/MED/41657774 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a14a01f38bef (Metraipolis archive dc_a14a01f38bef, sha256 1a1ad681ed0867f4b3db1607b591718e1fa23af2d3ac30c52682f0f09f92ef85)
BibTeX
@misc{dca14a01f38bef,
  title = {Integrative multi-omics and experimental analyses implicate PTK2 as a lorazepam-associated biomarker and potential therapeutic target in ovarian cancer — Europe PMC PMID:41657774},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41657774},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a14a01f38bef; sha256 1a1ad681ed0867f4b3db1607b591718e1fa23af2d3ac30c52682f0f09f92ef85},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41657774. Agents can read the archived copy with the MCP tool read_document.